article

1. Value of Ischemia and Coronary Anatomy in Prognosis and Guiding Revascularization Among Patients With Stable Ischemic Heart Disease..  Circulation. Cardiovascular imaging.  17:-. 2024
2. How to assess nonresponsiveness to vasodilator stress..  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.  -. 2024
3. Prevalence of balanced ischemia on positron emission tomography relative perfusion imaging among patients with high-risk coronary artery disease..  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.  -. 2024
4. Perivascular Adipose Tissue Inflammation: Does It Explain Sex-Based Differences in Atherosclerotic Heart Disease?.  Circulation. Cardiovascular imaging.  17:-. 2024
5. Atlas for reporting PET myocardial perfusion imaging and myocardial blood flow in clinical practice: an information statement from the American Society of Nuclear Cardiology..  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.  30:2850-2906. 2023
6. Systemic Inflammation With High-Sensitivity C-Reactive Protein and Atherosclerotic Plaque Progression..  JACC. Cardiovascular imaging.  17:212-213. 2023
7. Impact of Positron Emission Tomographic Myocardial Perfusion Imaging on Patient Selection for Revascularization..  Journal of the American College of Cardiology.  82:1662-1672. 2023
8. Prevalence and Prognostic Importance of Abnormal Positron Emission Tomography Among Asymptomatic Patients With Diabetes Mellitus..  JACC. Cardiovascular imaging.  17:301-310. 2023
9. Defining a Precise Diagnostic Strategy for Suspected Coronary Artery Disease-Lessons Learned From the PRECISE Trial..  JAMA cardiology.  8:902-903. 2023
10. ASNC model coverage policy: 2023 cardiac positron emission tomography..  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.  30:2114-2185. 2023
11. The Medicare Appropriate Use Criteria Program: A Review of Recommendations for Testing in Coronary Artery Disease..  Annals of internal medicine.  176:1235-1239. 2023
12. Coronary vascular dysfunction is associated with increased risk of death in patients with peripheral artery disease..  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.  30:2666-2675. 2023
13. Accurate and efficient rapid acquisition early post-injection stress-first CZT SPECT myocardial perfusion imaging with tetrofosmin and attenuation correction..  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.  30:2644-2654. 2023
14. Advances in Coronary Computed Tomographic Angiographic Imaging of Atherosclerosis for Risk Stratification and Preventive Care..  JACC. Cardiovascular imaging.  16:1099-1115. 2023
15. Improved Performance of PET Myocardial Perfusion Imaging Compared to SPECT in the Evaluation of Suspected CAD..  Current cardiology reports.  25:281-293. 2023
16. Myocardial Perfusion PET for the Detection and Reporting of Coronary Microvascular Dysfunction: A JACC: Cardiovascular Imaging Expert Panel Statement..  JACC. Cardiovascular imaging.  16:536-548. 2023
17. An Overlooked Cause of Myocardial Infarction With Normal Coronaries Presenting as Stress Cardiomyopathy in Females..  Cureus.  15:-. 2023
18. Next Frontier for Artificial Intelligence in Imaging: Moving Beyond Risk Prediction Toward Effective Implementation..  JACC. Cardiovascular imaging.  16:221-223. 2022
19. Association of Sex, Reduced Myocardial Flow Reserve, and Long-Term Mortality Across Spectrum of Atherosclerotic Disease..  JACC. Cardiovascular imaging.  15:1635-1644. 2022
20. The Potential of F-18 Flurpiridaz PET/CT Myocardial Perfusion Imaging for Precision Imaging..  Current cardiology reports.  24:987-994. 2022
21. Improving Symptoms and Quality of Life in Stable Coronary Artery Disease: An Evolving Paradigm..  Circulation.  145:1308-1311. 2022
22. Prognostic Relationship Between Coronary Artery Calcium Score, Perfusion Defects, and Myocardial Blood Flow Reserve in Patients With Suspected Coronary Artery Disease..  Circulation. Cardiovascular imaging.  15:-. 2022
23. Reclassification of Severe Ischemia on PET Versus SPECT MPI Using a Same-Patient Simultaneous Imaging Protocol..  JACC. Cardiovascular imaging.  15:1158-1159. 2022
24. Relationship Between Myocardial Perfusion Imaging Abnormalities on Positron Emission Tomography and Anginal Symptoms, Functional Status, and Quality of Life..  Circulation. Cardiovascular imaging.  15:-. 2022
25. Relative Prognostic Significance of Positron Emission Tomography Myocardial Perfusion Imaging Markers in Cardiomyopathy..  Circulation. Cardiovascular imaging.  14:-. 2021
26. Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure..  Circulation. Heart failure.  14:-. 2021
27. Development and Piloting of a Patient-Centered Report Design for Stress Myocardial Perfusion Imaging Results..  JAMA network open.  4:-. 2021
28. Reasons for discordance between positron emission tomography (PET) myocardial perfusion imaging (MPI) results and subsequent management..  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.  29:1109-1116. 2021
29. Variability in utilization of diagnostic imaging tests in patients with symptomatic peripheral artery disease..  International journal of cardiology.  200-206. 2021
30. Association of Diabetes Mellitus With Health Status Outcomes in Patients With Peripheral Artery Disease: Insights From the PORTRAIT Registry..  Journal of the American Heart Association.  9:-. 2020
31. Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study..  Diabetes, obesity & metabolism.  23:39-48. 2020
32. Stress myocardial perfusion imaging in patients presenting with syncope: Comparison of PET vs. SPECT..  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.  28:2895-2906. 2020
33. Temporal trends in test utilization and prevalence of ischaemia with positron emission tomography myocardial perfusion imaging..  European heart journal. Cardiovascular Imaging.  21:318-325. 2020
34. Mental health concerns in patients with symptomatic peripheral artery disease: Insights from the PORTRAIT registry..  Journal of psychosomatic research.  -. 2020
35. Changes in Health and Well-Being during Residents' Training..  Southern medical journal.  113:70-73. 2020
36. Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization..  European heart journal.  41:759-768. 2020
37. Extent of Myocardial Ischemia on Positron Emission Tomography and Survival Benefit With Early Revascularization..  Journal of the American College of Cardiology.  74:1645-1654. 2019
38. Ischemia on PET MPI May Identify Patients With Improvement in Angina and Health Status Post-Revascularization..  Journal of the American College of Cardiology.  74:1734-1736. 2019
39. Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients..  JACC. Cardiovascular imaging.  12:1821-1831. 2019
40. Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry..  JACC. Heart failure.  7:350-358. 2019
41. Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease..  Journal of the American Heart Association.  8:-. 2019
42. Drivers of radiation dose reduction with myocardial perfusion imaging: A large health system experience..  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.  27:785-794. 2019
43. Blood pressure management in patients with symptomatic peripheral artery disease: insights from the PORTRAIT registry..  European heart journal. Quality of care & clinical outcomes.  5:79-81. 2019
44. Guideline-directed statin intensification in patients with new or worsening symptoms of peripheral artery disease..  Clinical cardiology.  41:1414-1422. 2018
45. Underutilization of Evidence-Based Smoking Cessation Support Strategies Despite High Smoking Addiction Burden in Peripheral Artery Disease Specialty Care: Insights from the International PORTRAIT Registry..  Journal of the American Heart Association.  7:-. 2018
46. Low Diastolic Blood Pressure Is Associated With Angina in Patients With Chronic Coronary Artery Disease..  Journal of the American College of Cardiology.  72:1227-1232. 2018
47. Preoperative dobutamine stress echocardiography in patients undergoing orthotopic liver transplantation..  Clinical cardiology.  41:931-935. 2018
48. Prognosticating in the Very Elderly..  Circulation. Cardiovascular imaging.  11:-. 2018
49. Validation of the Seattle angina questionnaire in women with ischemic heart disease..  American heart journal.  117-123. 2018
50. The association of invasive treatment with health status outcomes in patients with non-ST-elevation myocardial infarction and pre-infarct angina..  European heart journal. Quality of care & clinical outcomes.  4:142-143. 2018
51. Relation of Age and Health-Related Quality of Life to Invasive Versus Ischemia-Guided Management of Patients with Non-ST Elevation Myocardial Infarction..  The American journal of cardiology.  121:789-795. 2018
52. Association Between Prompt Defibrillation and Epinephrine Treatment With Long-Term Survival After In-Hospital Cardiac Arrest..  Circulation.  137:2041-2051. 2017
53. Association of low-density lipoprotein pattern with mortality after myocardial infarction: Insights from the TRIUMPH study..  Journal of clinical lipidology.  11:1458-1470.e4. 2017
54. Prevalence of Elevated Cardiovascular Risks in Young Adults: A Cross-sectional Analysis of National Health and Nutrition Examination Surveys..  Annals of internal medicine.  166:876-882. 2017
55. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial)..  Circulation. Cardiovascular quality and outcomes.  10. 2017
56. Characteristics and outcomes of patients with postoperative cardiovascular pseudoaneurysms..  The Journal of thoracic and cardiovascular surgery.  153:43-50. 2016
57. Post-acute Care Trajectories in the First Year Following Hospital Discharge After Left Ventricular Assist Device Implantation..  Journal of the American Medical Directors Association.  17:908-12. 2016
58. Characteristics and Outcomes of Patients Presenting With Hypertensive Urgency in the Office Setting..  JAMA internal medicine.  176:981-8. 2016
59. Synergistic Utility of Brain Natriuretic Peptide and Left Ventricular Global Longitudinal Strain in Asymptomatic Patients With Significant Primary Mitral Regurgitation and Preserved Systolic Function Undergoing Mitral Valve Surgery..  Circulation. Cardiovascular imaging.  9. 2016
60. Effect of Pulmonary Vascular Pressures on Long-Term Outcome in Patients With Primary Mitral Regurgitation..  Journal of the American College of Cardiology.  67:2952-61. 2016
61. The use of pre-existing CT imaging in screening for abdominal aortic aneurysms..  Vascular medicine (London, England).  21:515-519. 2016
62. Preventable Admissions on a General Medicine Service: Prevalence, Causes and Comparison with AHRQ Prevention Quality Indicators-A Cross-Sectional Analysis..  Journal of general internal medicine.  31:597-601. 2016
63. Probability of developing proximal deep-vein thrombosis and/or pulmonary embolism after distal deep-vein thrombosis..  Thrombosis and haemostasis.  115:608-14. 2015
64. Prognostic Utility of Brain Natriuretic Peptide in Asymptomatic Patients With Significant Mitral Regurgitation and Preserved Left Ventricular Ejection Fraction..  The American journal of cardiology.  117:258-63. 2015
65. Stress echocardiography in valvular heart disease: a current appraisal..  Expert review of cardiovascular therapy.  13:249-62. 2015